South Korea’s antitrust regulator has concluded its review of the controversial merger between SK Telecom and CJ HelloVision, ending seven months of assessments on the possibility of the deal impeding fair market competition, according to industry sources Monday.
The Fair Trade Commission has reportedly sent its report to SK Telecom, they said without elaborating. The state-run regulatory body will also send the review to the Korea Communications Commission and the Ministry of Science, ICT and Future Planning at a later date. Meanwhile, the regulator will give the telecom giant two weeks to contemplate the report.
The FTC spent more than half a year deciding on how far it would make correction orders to SK Telecom regarding the deal’s possible impact on damaging market competitiveness. It has no authority for an approval, but the KCC and the Future Ministry have.
Based on the report by FTC, the KCC and the ministry are expected to make a final decision at the end of the month.
Unlike the FTC’s limited role that only looked into the possibility of the deal hurting market competition, the KCC and the ministry are likely to examine whether the takeover violates the public interest or not.
Full Content: Korea Herald
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas